FDA 21 CFR Part 11 is a regulation that establishes the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records by the FDA. This regulation is crucial for ensuring the integrity of data in various industries, including the rapidly evolving field of Nanotechnology.
